Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet. - Wikidata - awgldk - TriplyDB

Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.

Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.

http://www.wikidata.org/entity/Q33365640

about

Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura Current concepts in thrombotic thrombocytopenic purpura A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.Treatment of thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.Investigational drugs in thrombotic thrombocytopenic purpura.Plasma components: properties, differences, and uses.ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw.Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma.Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.Cryosupernatant and Immunosuppression as Effective Alternative Therapies for TTP in Three Pediatric SLE Patients.Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center Experience Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials.Stability of Thawed Apheresis Fresh-Frozen Plasma Stored for up to 120 Hours at 1°C to 6°C.Quality Assessment of Established and Emerging Blood Components for Transfusion.Management of thrombotic thrombocytopenic purpura: current perspectives Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.Randomized controlled trials in therapeutic apheresis.Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.

P2860

Q24241470-7D9CF3DA-F70F-4A42-99D0-D2943D4A02AB Q24656680-370DDD0E-5892-4CCB-AE8F-BDAFAB94F343 Q30441694-DDB61FA1-513B-4BC7-BDCC-C9E35F266552 Q33370956-C36E956C-6F0B-4258-A556-1E40925F633D Q33376071-DBF1F3F7-FDF1-4969-9056-EF98B8774D7C Q33376161-1AF6986B-8EE8-46EC-984B-881864688CEC Q33382999-2744D1D6-86F5-4C7A-9D85-318328211346 Q33395696-C5F99F4B-8D95-4971-8080-1182BEE64D5D Q33401173-5060EC34-447F-42F3-ABE5-CDD5E66CD1AC Q33406892-CFBAF036-1515-421A-9F01-1B1310BE7A12 Q33407886-C142C89D-64C9-4E7A-ACE0-9E10E099C5DD Q33411009-4D91A48D-A12F-42D5-93EB-2EF44C3D5A2D Q33415330-236E8978-7B9D-4A2A-AC7B-40F0C4718339 Q33415693-DFEDA5C1-0340-47E1-B95B-F5BD9B5B0B08 Q33418313-00D7FFB6-CF7D-45AD-8C77-64EE59CE442B Q34038164-82AFB632-8E35-4D64-A41D-06072C84A5E7 Q34132303-5A7C7282-3248-4783-BEDC-F9E5D43E7C27 Q37483387-9C7B3CC0-626F-471C-B029-1D3C60226365 Q37539104-D4499523-3F0D-4614-9EC9-29514AF3DB83 Q37577785-A91DA460-99BB-46AA-B3B7-28DB051D5D71 Q37820338-187F755D-D3D9-4120-B75B-E80059AF8464 Q38078306-AA1DB916-003D-4301-BE01-C5216D2227CA Q38736033-A6217EF3-1A4E-4CBC-A8C7-13A4A60C4791

P2860

Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.

http://www.wikidata.org/entity/Q33365640

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Does cryosupernatant plasma im ...... openic purpura? No answer yet.

@ast

Does cryosupernatant plasma im ...... openic purpura? No answer yet.

@en

type

label

Does cryosupernatant plasma im ...... openic purpura? No answer yet.

@ast

Does cryosupernatant plasma im ...... openic purpura? No answer yet.

@en

prefLabel

Does cryosupernatant plasma im ...... openic purpura? No answer yet.

@ast

Does cryosupernatant plasma im ...... openic purpura? No answer yet.

@en

P1433

Q33365640-2B25ACBF-9447-4624-91BD-B977387D87FA

P1476

Q33365640-44599A53-A3BB-4573-A8E9-E43E9ADBC2A4

P2093

Q33365640-00F887B2-220E-45AD-B37A-BF3CDF4281F9

Q33365640-1C0F19CB-2B4B-40FA-B7E9-C1BC489E7CBC

Q33365640-300F463D-B7BA-40EC-8C75-DC95A1A096EF

Q33365640-5780F826-B31B-4115-9DB3-5247DF3DBAFF

Q33365640-648BBBA3-A10F-4883-9A1A-8031CFB3C10D

Q33365640-6C8CFBDC-0897-48A9-AD13-F9F55ED0314C

Q33365640-8A66F10B-1643-435F-AA67-2F6931C1743C

Q33365640-92173256-2DA2-4E6B-8250-87519886A8CF

Q33365640-D5D3DCEC-B1CD-4576-942C-0EA9B08C15C2

Q33365640-FE7154F4-6DD8-429D-B80C-5187C8EF9AEF

P2860

Q33365640-08712A42-9CFE-4677-AF63-5ED45955A37D

Q33365640-1350EF23-ADED-4C41-BE29-9BDFC41C6E50

Q33365640-1E652EFF-FF3E-4112-87D0-CD387ACE7DAB

Q33365640-2A54B46E-6801-4C43-8F23-165587C23E29

Q33365640-3E53E8AF-4E93-43DE-AF21-8DF65B830A68

Q33365640-48A68AED-C2AF-48ED-8ACD-439B694F8470

Q33365640-770454F8-8AFC-4431-BFB6-7AA9A1BA9F94

Q33365640-A2DA65FC-A01E-421F-8EF0-4F1E6688D7C6

Q33365640-B0C87C76-C36C-480D-B0B6-B6CC7F650E1D

Q33365640-CC7FE4AB-79D3-44BE-903B-25DF5AE6FC00

P304

Q33365640-F9BA271E-94F7-4028-B280-D2977D6DCEC1

P31

Q33365640-F81D3D65-683F-4248-BCB4-94F62A7FCF60

P356

Q33365640-3E104482-6226-469F-A4AF-767EFF12545D

P407

Q33365640-FEE69834-7B02-42D2-9BB1-35DE3ECA90E0

P433

Q33365640-E44474C2-EA35-4713-BBBB-196D750C9846

P478

Q33365640-8F2880DC-683B-4A0A-98F0-CF7E766D8F04

P577

Q33365640-53F4D269-4A2A-404A-823F-2412CF94262D

P5875

Q33365640-3A75E911-EDBD-4D4A-BF7D-2E7485268265

P698

Q33365640-D6FE2456-3592-465F-BD19-3AE5B00AE00D

P921

Q33365640-A49A55FA-ABFF-46C0-81AC-E187CA79EBB1

P356

J.1365-2141.2005.05418.X

P1433

British Journal of Haematology

P1476

Does cryosupernatant plasma im ...... openic purpura? No answer yet.

@en

P2093

Canadian Apheresis Group

http://www.w3.org/2001/XMLSchema#string

Canadian Association of Apheresis Nurses

http://www.w3.org/2001/XMLSchema#string

David Anderson

http://www.w3.org/2001/XMLSchema#string

David Sutton

http://www.w3.org/2001/XMLSchema#string

Douglas Palmer

http://www.w3.org/2001/XMLSchema#string

Gail Rock

http://www.w3.org/2001/XMLSchema#string

George Wells

http://www.w3.org/2001/XMLSchema#string

Marion Sternbach

http://www.w3.org/2001/XMLSchema#string

Pierre Leblond

http://www.w3.org/2001/XMLSchema#string

William Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders.

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.

Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation.

Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins.

Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.

P304

79-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2005.05418.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7934102

http://www.w3.org/2001/XMLSchema#string

P698

15801959

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia